Song, Y., Wang, Z., Wang, N., Xie, X., Zhu, T., Wang, Y. (2025). A real-world pharmacovigilance study of omalizumab using disproportionality analysis in the FDA adverse drug events reporting system database. Scientific Reports. https://doi.org/10.1038/s41598-025-91463-5